👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr.
Dr. Marco Gerlinger
Oncology
English
German
3,725+
Patients seen
13
Years in practice
3
Publications
2
Languages spoken
About
Professor Marco Gerlinger, MD FRCP, specialises in the treatment of patients with bowel, stomach and oesophageal cancers at LOC Harley Street, The Harley Street Clinic and Nuffield St Barts. He is a Consultant Medical Oncologist, Chair of Gastrointestinal Cancer Medicine, and the Director of GI Cancer Research at St Bartholomew's Hospital and Queen Mary University of London.
Prof Gerlinger studied Medicine at the University of Munich, Harvard Medical School and Imperial College and obtained his research MD from the Institute of Immunology in Munich. He trained in General Medicine and Medical Oncology in Zurich and London and undertook post-doctoral research training in Zurich and at the CRUK London Research Institute (now The Francis Crick Institute).
In 2013, Prof Gerlinger joined the Royal Marsden Hospital as a consultant in GI cancer and the Institute of Cancer Research as a research team leader. He was subsequently appointed at St Bartholomew's Hospital and Queen Mary University in 2022.
With his clinical and research teams, he leads clinical trials and develops precision medicines including antibody drug conjugates and immunotherapies for colorectal, stomach and oesophageal cancers.
Prof Gerlinger has served as faculty member for the largest international oncology meetings including the American Society of Clinical Oncology Annual Meetings and the European Society of Medical Oncology Annual Meetings. He has furthermore served twice on the ESMO Annual Meeting lower GI cancer track Scientific Committee and is one of the few Europeans who served as track chair on the American Association of Cancer Research Annual Meeting. He has been awarded multiple prestigious research grants from the European Commission, Cancer Research UK, the UK Medical Research Council and the National Institute of Health Research.
Prof Gerlinger studied Medicine at the University of Munich, Harvard Medical School and Imperial College and obtained his research MD from the Institute of Immunology in Munich. He trained in General Medicine and Medical Oncology in Zurich and London and undertook post-doctoral research training in Zurich and at the CRUK London Research Institute (now The Francis Crick Institute).
In 2013, Prof Gerlinger joined the Royal Marsden Hospital as a consultant in GI cancer and the Institute of Cancer Research as a research team leader. He was subsequently appointed at St Bartholomew's Hospital and Queen Mary University in 2022.
With his clinical and research teams, he leads clinical trials and develops precision medicines including antibody drug conjugates and immunotherapies for colorectal, stomach and oesophageal cancers.
Prof Gerlinger has served as faculty member for the largest international oncology meetings including the American Society of Clinical Oncology Annual Meetings and the European Society of Medical Oncology Annual Meetings. He has furthermore served twice on the ESMO Annual Meeting lower GI cancer track Scientific Committee and is one of the few Europeans who served as track chair on the American Association of Cancer Research Annual Meeting. He has been awarded multiple prestigious research grants from the European Commission, Cancer Research UK, the UK Medical Research Council and the National Institute of Health Research.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Marco Gerlinger
Education & training
-
2003–2009 MD · Medicine and Surgery
-
2009–2013 Residency · Oncology
Career & appointments
-
2013-09–2014-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Generali Healthcare · 1,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,530 |
| Annual physical exam | 99395 | 508 |
| Vaccination administration | 90471 | 2,716 |
| Minor procedure (skin) | 17110 | 1,803 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 10
-
Validation of clinical scoring in Oncology
DOI: 10.3731/euroclin.2026.0 · PMID: 35740880 · cited by 18
-
Long-term follow-up of Oncology across
DOI: 10.6968/euroclin.2025.1 · PMID: 30972686 · cited by 64
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2014
- national college of family doctors — Member · since 2014
- European Union of Medical Specialists (UEMS) — Member · since 2014
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.73
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.88
- Value For Money
- 4.90
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · marco.gerlinger@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
